According to new research from The University of Texas MD Anderson Proton Therapy Center.

.. APBI with proton therapy less costly than other traditional treatments for early stage breasts cancer Findings may challenge assumption that proton therapy is more costly than other traditional treatments and supports case for insurance coverage In terms of length of treatment and cost, sufferers with early stage breasts cancer may benefit from accelerated partial breasts irradiation with proton therapy versus whole breast irradiation , according to new research from The University of Texas MD Anderson Proton Therapy Center. In a cost evaluation study based on typical patient features, researchers used Medicare reimbursement codes to investigate allowable charges for eight various kinds of partial and entire breast irradiation therapies and treatment schedules available to early stage breast cancer patients.The Ba/F3 cells expressing the 52-bp deletion demonstrated cytokine-independent proliferation. However, the growth of Ba/F3 cells expressing nonmutant and mutant calreticulin was suppressed similarly on treatment with a JAK2 kinase inhibitor, suggesting that the JAK-STAT pathway is required for cytokine-independent proliferation induced by mutant calreticulin. Relative to this finding, we detected increased phosphorylation of STAT5 in the Ba/F3 cells with the 52-bp deletion, both in the absence and in the presence of stimulation by interleukin-3.